Example: marketing
Born Too Soon - World Health Organization
Care, antenatal corticosteroids); research and development of new interventions; and tools to better understand the burden and reduce the incidence of preterm birth, such as the Lives Saved Tool and MANDATE Project. CORE Group will increase awareness about practical steps to prevent and treat preterm complications to the
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
NICE Guidelines on Pre-Eclampsia
action-on-pre-eclampsia.org.ukantenatal corticosteroids if indicated, if early birth is planned for women with preterm pre-eclampsia, in line with the NICE guideline on preterm labour and birth. Post birth. •In the early post-partum period, women with pre-eclampsia should
Maternity care for mothers and babies during the COVID …
www.health.qld.gov.au• Arrange alternate mode of antenatal care (e.g. telehealth) if care cannot be delayed • Resume usual antenatal care after release from self-quarantine or self-isolation • Advise to telephone maternity service if concerned
EMERGENCY OBSTETRIC AND NEWBORN CARE: the DOH ... - …
cebunursinginformatics.weebly.comEssential Elements of Antenatal Care No fetal movement Ruptured membranes and no labor Fever or burning urination Vaginal discharge Signs suggesting HIV infection Smoking, alcohol or drug abuse Cough or breathing difficulty Taking anti-TB drugs > 8 months No clear evidence of benefit of routine antibiotic and steroid use < 8 months Give antibiotic:
Maternity and Neonatal Clinical Guideline - Queensland Health
www.health.qld.gov.au• Consider corticosteroids if preterm labour anticipated • Strict fluid management • FBC, ELFT including urate & LDH • Coagulations screen • Urine for protein to creatinine ratio • Consider transfer to higher level facility, if required
Primary Care Management of Nausea and Vomiting In Early ...
www.nottsapc.nhs.ukBMJ 2011;342:d3606, CKS Nausea/vomiting in pregnancy, Feb 2020, NICE CG62: Antenatal care, Feb 2019, RCOG:The management of nausea and vomiting of pregnancy and hyperemesis gravidarum, 2016, MHRA Drug safety update 2020: Ondansetron: small increased risk of oral clefts following use in the first 12 weeks of pregnancy.